课题基金 / 基金详情

A MULTICENTER PHASE 1-2A STUDY OF DIMEBON IN SUBJECTS WITH HUNTINGTON'S DISEASE

A MULTICENTER PHASE 1-2A STUDY OF DIMEBON IN SUBJECTS WITH HUNTINGTON'S DISEASE
DIMEBON 在亨廷顿病受试者中的多中心 1-2A 期研究
批准号：
7606592
负责人：
JODY COREY-BLOOM
金额：
$0.58万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606592
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseFundingGrantHuntington DiseaseInstitutionPhaseResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of Healthdimebolindosage

项目摘要

项目成果

JODY COREY-BLOOM的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 确定轻中度亨廷顿病患者在剂量递增期间口服迪美朋的安全性和耐受性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the safety and tolerability of orally administered Dimebon during dosage escalation in subjects with mild to moderate Huntington's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FRONTOSTRIATAL ACTIVATION IN SUBJECTS AT RISK FOR HUNTINGTON'S DISEASE
CLINICAL TRIAL: ACR16 VERSUS PLACEBO FOR THE SYMPTOMATIC TREATMENT OF HUNTINGTON
CLINICAL TRIAL: PHASE 3 STUDY OF DIMEBON IN PATIENTS WITH MILD-TO-MODERATE HUNTI
CLINICAL TRIAL: COOPERATIVE HUNTINGTON'S OBSERVATIONAL TRIAL (COHORT)
海外基金